You are here

Award Data

For best search results, use the search terms first and then apply the filters
Reset

The Award database is continually updated throughout the year. As a result, data for FY24 is not expected to be complete until March, 2025.

Download all SBIR.gov award data either with award abstracts (290MB) or without award abstracts (65MB). A data dictionary and additional information is located on the Data Resource Page. Files are refreshed monthly.

The SBIR.gov award data files now contain the required fields to calculate award timeliness for individual awards or for an agency or branch. Additional information on calculating award timeliness is available on the Data Resource Page.

  1. STTR Phase I: XERICO-Mediated Drought Tolerance Technology

    SBC: KOPESS AgTech LLC            Topic: BT

    The broader impact/commercial potential of this Small Business Technology Transfer (STTR) project is the development of drought-tolerant crops through biotechnology, which is potentially both economically and environmentally important. Genetic engineering of drought tolerance has been very recalcitrant because of the complexity of plant responses to water stress. The proposed technology offers nov ...

    STTR Phase I 2017 National Science Foundation
  2. SBIR Phase I: Nanostructured High-Strength Magnet for Automotive Applications

    SBC: GRID LOGIC INCORPORATED            Topic: MN

    The broader impact/commercial potential of this Small Business Innovation Research Phase I project is to develop an improved permanent magnet that will allow cost reduction and/or vehicle weight reduction in automotive applications. This permanent magnet product will be fabricated from samarium cobalt magnetic particles that are encapsulated with a nanometer scale coating of iron or cobalt metal. ...

    SBIR Phase I 2017 National Science Foundation
  3. SBIR Phase I: Whole Genome Sequencing Data to Insight in One Hour

    SBC: ParaBricks LLC            Topic: BT

    The broader impact/commercial potential of this Small Business Innovation Research (SBIR) project will be to provide deep insights into the DNA of patients in one hour at one-fourth the cost. This will allow hospitals, clinics and research centers to delve faster into the genetic information of the patients and return essential insights to physicians, leading to faster decisions on therapy. Analyz ...

    SBIR Phase I 2017 National Science Foundation
  4. SBIR Phase I: An Automated Tool to Measure and Predict Substance Use Recovery

    SBC: WORKIT HEALTH INC            Topic: SH

    The broader impact of this Small Business Innovation Research (SBIR) Phase I project is to improve access to high-quality, responsive, and evidence-based treatments for risky users of alcohol and other drugs. Current standards of care are cost-prohibitive, time-intensive and overly reliant on community support groups lacking a scientific basis or a mechanism for accountability. The research propos ...

    SBIR Phase I 2017 National Science Foundation
  5. SBIR Phase II: Game-Based Learning for Organic Chemistry Using Mechanisms

    SBC: ALCHEMIE SOLUTIONS, INC.            Topic: EA

    This Small Business Innovation Research Phase II project answers the call that science students go beyond memorizing facts to understand content on a deeper, conceptual level. In chemistry, this goal is particularly difficult to achieve because the underlying concepts describe the behaviors of particles that are not directly observable to students. College instructors are also under added pressure ...

    SBIR Phase II 2017 National Science Foundation
  6. SBIR Phase II: Efficient Production of a High Performance and Eco-Friendly Superabsorbent Microbial Biopolymer for Hygiene Applications

    SBC: ECOVIA RENEWABLES INC.            Topic: CT

    The broader impact/commercial potential of this Small Business Innovation Research Phase II project includes tremendous commercial potential, societal benefits, and scientific advances. Conventional superabsorbent polymers (SAP) are based on polyacrylates or polyacrylamides derived from petroleum feedstock. They are widely used in the absorbent cores of hygiene products, with disposable diapers re ...

    SBIR Phase II 2017 National Science Foundation
  7. Microneedle Delivery of Zanamivir for Treatment of Influenza Infections

    SBC: TSRL, INC.            Topic: NIAID

    Abstract Yearly influenza epidemics strike millions of peoplecausing up todeathsFatality caused by most seasonal influenza viruses is ltbut with significant mortality in the young and the elderly populationsWhen a new pathogenic influenza strain enters the populationa pandemic could kill tens of millions of people with a negative economic impact estimated to be overbillion dollarsInfluenza virus i ...

    SBIR Phase I 2017 Department of Health and Human ServicesNational Institutes of Health
  8. Geostatistical software for space-time interpolation and uncertainty modeling

    SBC: BIO-ANALYTICS, INC.            Topic: NIEHS

    DESCRIPTIONprovided by applicantA key component in any investigation of association and or cause effect relationships between the environmente gair pollutionheat wavesand health outcomese gasthmaheart diseasecanceris the availability of accurate models of exposure at the same geographical scale and temporal resolution as the health outcomesThe computation of human exposure is particularly challeng ...

    SBIR Phase II 2017 Department of Health and Human ServicesNational Institutes of Health
  9. De-risking ONL1204 to enable venture capital investment for first-in-human clinical trials

    SBC: ONL Therapeutics, Inc.            Topic: NEI

    PROJECT SUMMARYABSTRACTRetinal degenerative disease and injury are among the leading causes of irreversible vision loss and blindness in the United States and the developed worldaffecting hundreds of thousands of people every year and resulting in billions of dollars in added healthcare costs and lost productivityPhotoreceptor cell death is a consequence of many of these acute and chronic retinal ...

    SBIR Phase II 2017 Department of Health and Human ServicesNational Institutes of Health
  10. Development of MTX for the Treatment of KRAS Mutant Colorectal Cancer

    SBC: Mekanistic Therapeutics, LLC            Topic: NCI

    PROJECT SUMMARY Mekanistic Therapeutics seeks to design discover and develop anti cancer agents that selectively inhibit multiple oncogenic pathways Its lead agent MTX was discovered in collaboration with the Leopold laboratory at University of Michigan MTX is a novel kinase inhibitor showing early promise for its therapeutic potential against solid cancers refractory to current treatm ...

    STTR Phase I 2017 Department of Health and Human ServicesNational Institutes of Health
US Flag An Official Website of the United States Government